CancerSCAN is a cancer genome diagnosis solution for anticancer therapy that is customized to individuals, developed for the first time in Korea as a product of joint research with the clinicians at the Samsung Genome Research Center. It is based on NGS technology that accurately detects the diverse types of patient specimen mutations accurately and predicts patient prognosis through a database by selecting an optimal targeted anticancer agent and immuno-oncology most appropriate for the patient via a panel developed on the basis of several years of clinical experience.In addition, our company has developed OncoSTATION which encompasses the entire range of processes from automated experimentation and analysis data quality management system (laboratory information management system - LIMS) to data processing, QC, mutation detection, annotation and report generation, and providing related services in association with CancerSCAN In order to supplement the environmental difficulties in NGS clinical examinations in Korea (specialized personnel and equipment, etc.).
Provision of all-in-one service that includes
library prep kit, panel, data analysis and management software
Panel customizing as
per customer needs
Provision of accurate results
appropriate for needs through many years
of extensive clinical sample analysis experience
Analytic evaluation was conducted through the analysis of the combination of more than 40 types of cancer cell lines known to have diverse types of mutations.
|Used Cell line||Pooled set||n||Sensitivity Ratio||C.I.||n||PPV Ratio||C.I.|
|Service||Cancer type||Number of genes|
|2||CancerSCAN IO +||Pan-cancer||407|